Claude Visuals lets users prompt “Show me” to get interactive graphs and comparisons, with Opus delivering the strongest ...
The Motley Fool reports that biotech stocks surged in 2025, driven by FDA approvals and a doubling of longevity investment to $8.49 billion.
A market crash puts long-term savings under a microscope. For many people, that means deciding whether to stick with a plan or change course.